±¹³» ù Äڷγª19 ȯÀÚ ÀÓ»óÁõ·Ê, ‘À±±¤¿ÀÇÇÐ»ó’ ¼ö»ó
14ÀÏ, ´ëÇÑÀÇÇÐȸ Á¤±âÃÑȸ¿¡¼ ÃÖ¿ì¼ö³í¹® ¼±Á¤
|
»çÁø) »çÁø ÁÂÃø¿¡¼ µÎ ¹ø°°¡ ¹Ú»óÁØ ±³¼ö |
[º¸°ÇŸÀÓÁî] ±¹³» Äڷγª19 ȯÀÚ(3¹ø È®ÁøÀÚ)ÀÇ ÀÓ»ó Áõ·Ê¸¦ ÃÖÃÊ º¸°íÇÑ ¸íÁöº´¿ø ¹Ú»óÁØ ±³¼öÀÇ ³í¹®ÀÌ ´ëÇÑÀÇÇÐȸ JKMS(Journal of Korean medical science) 10³â ¿ª»ç»ó Àü ¼¼°èÀûÀ¸·Î °¡Àå ¸¹ÀÌ ÀοëµÈ ³í¹®À¸·Î ¼±Á¤µÆ´Ù.
´ëÇÑÀÇÇÐȸ´Â Áö³ 14ÀÏ ¿ÀÈÄ ½¦¶óÅ漿ïÆÈ·¡½º°³²È£ÅÚ¿¡¼ °³ÃÖµÈ 2021³â Á¤±âÃÑȸ¿¡¼ ¸íÁöº´¿ø ¹Ú»óÁØ ±³¼ö(È£Èí±â³»°ú, ¿¬±¸ºÎ¿øÀå)¿¡°Ô Á¦12ȸ À±±¤¿ ÀÇÇлóÀ» ¼ö¿©Çß´Ù.
À±±¤¿ ÀÇÇлóÀº ±¹³» ÇÐÀÚµéÀÇ ¼¼°èÀûÀÎ ¿¬±¸ ¾÷ÀûÀ» ±¹³» ÇмúÁö¿¡ Åõ°íÇÏ´Â °ÍÀ» Àå·ÁÇÏ°í À̸¦ ÅëÇØ Çѱ¹ ÀÇÇÐ ÇмúÁöÀÇ ±¹Á¦È¸¦ °ßÀÎÇϱâ À§ÇØ ´ëÇÑÀÇÇÐȸ¿Í ºÎäǥ °¡¼ÛÀç´ÜÀÌ 2009³â °øµ¿ Á¦Á¤ÇÑ »óÀ¸·Î ºÎ»óÀº »ó±Ý 1,000¸¸¿øÀÌ´Ù.
¹Ú»óÁØ ±³¼ö´Â Áö³ 2020³â 2¿ù JKMS 35±Ç 6È£¿¡ ³»±¹ÀÎ Äڷγª19 ȯÀÚÀÇ ÀÓ»ó Áõ·Ê¸¦ ´ãÀº ³í¹®À» ±¹³» ÃÖÃÊ·Î ¹ßÇ¥, ±¹³»ÀÇ ³ôÀº ÀÇÇÐ ¿¬±¸ ¼öÁØÀ» ¼¼°è¿¡ ¾Ë¸®´Âµ¥ ±â¿©ÇÑ °ø·Î·Î ÀÌ »óÀ» ¼ö¿©ÇÏ°Ô µÆ´Ù.
¹Ú»óÁØ ±³¼ö´Â ‘Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR’(3Â÷ Àü¿°ÀÌ È®ÀÎµÈ ±¹³» ÃÖÃÊÀÇ COVID-19 ȯÀÚ Áõ·Ê º¸°í : Á¤·®Àû RT-PCR·Î ÃßÀû °üÂûÇÑ COVID-19 Æó·ÅÀÇ Lopinavir/Ritonavir Ä¡·á °æÇè) ³í¹®ÀÇ Ã¥ÀÓÀúÀڷμ ¼ö»óÀÇ ¿µ¿¹¸¦ ¾È¾Ò´Ù.
´ëÇÑÀÇÇÐȸ JKMSÀÇ È«¼ºÅ ÆíÁýÀÎÀº “¹Ú»óÁØ ±³¼ö¸¦ Ã¥ÀÓÀúÀÚ·Î 8¸íÀÇ ¸íÁöº´¿ø ¼Ò¼Ó °øÀúÀÚµéÀÇ ‘3¹ø ȯÀÚ ÀÓ»ó Áõ·Ê ³í¹®’Àº Áö³ 10³â°£ JKMS¿¡ Ãâ°£ÇÑ ³í¹® Áß ±¹³»¿Ü¿¡¼ ÀοëÁö¼ö°¡ °¡Àå ³ô¾Ò´Âµ¥, ƯÈ÷ ÇØ¿ÜÀÇ ÁÁÀº ÇмúÁö¿¡¼ ÀοëÀ» ¸¹ÀÌ ¹ÞÀº ³í¹®”À̶ó°í ¹àÇû´Ù.
ÀÌ ³í¹®Àº ȯÀÚÀÇ ÀüÇüÀûÀÎ ÀÓ»ó°úÁ¤¿¡ ´ëÇÑ ÀÚ·á»Ó¸¸ ¾Æ´Ï¶ó, Æó·Å Ä¡·á °úÁ¤¿¡¼ Ç×AIDSÄ¡·áÁ¦ÀÎ Ä®·¹Æ®¶óÀÇ È¿´ÉÀ» Æò°¡Çß´Ù´Â Â÷¿ø¿¡¼ ¸¹Àº ÁÖ¸ñÀ» ¹Þ¾Æ¿Ô´Ù.
ÀÌ ³í¹®¿¡´Â Ã¥ÀÓÀúÀÚ ¹Ú»óÁØ ±³¼ö ¿Ü¿¡µµ ÃÖ°¿ø ±³¼ö, ÀÌ¿ÕÁØ ÀÌ»çÀå, ÀÓÀç±Õ ±³¼ö, °À¯¹Î ±³¼ö, ½ÅÇö¿µ ±³¼ö, ±è¹®Á¤ ±³¼ö, À̹é½Â ±³¼ö(´ºÈ£¶óÀÌÁðÇ׾Ͽ¬±¸¼Ò), Àü½ÂÇö ¿¬±¸¿ø(´ºÈ£¶óÀÌÁð Ç׾Ͽ¬±¸¼Ò), ¼ºÀ¯¹Î Àü°øÀÇ µîÀÌ Âü¿©Çß´Ù.
¹Ú»óÁØ ±³¼ö´Â “±¹³» ¼¼ ¹ø° Äڷγª19 ȯÀÚ¸¦ Ä¡·áÇÏ¸é¼ ÃßÈÄ ¹ß»ýÇϴ ȯÀÚ¸¦ Ä¡·áÇÏ°Ô µÉ ÀÇ·áÁø¿¡°Ô Á¶±ÝÀ̳ª¸¶ µµ¿òÀ» ÁÖ·Á°í ÀÓ»óÁõ·Ê¸¦ ½Å¼ÓÇÏ°Ô º¸°íÇÏ°Ô µÆ´Ù”¸ç “±¹³»´Â ¹°·Ð ÇØ¿Ü¿¡¼µµ ¸¹ÀÌ Àοë, ȯÀÚÄ¡·á¿¡ µµ¿òÀÌ µÆ´Ù´Ï Å« º¸¶÷À» ´À³¤´Ù”°í ¼ö»ó ¼Ò°¨À» ¹àÇû´Ù.
°ü·Ã ³í¹® ¸µÅ© https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e79